The International Myeloma Foundation is committed to action on issues that affect patients and their families. Through our advocacy efforts, we ensure that the patient perspective is heard when legislators consider important and impactful changes to the health care systems of each state. Our advocacy team is constantly monitoring potential issue areas that could have an impact on the myeloma community.
Equally important are the efforts of our patient advocates. The advocacy team trains and guides patients and family through the pitfalls of patient activism at the state level and provides opportunities for every patient to take action from their own home. With your help, the IMF supports legislation that betters the lives of multiple myeloma patients in all 50 states.
The IMF tracks state health policy issues that will affect the multiple myeloma community. Since 2010 we have been working to pass Oral Anticancer Treatment Access Legislation. As of April 2017, 43 States and Washington, D.C. have passed this type of law. You can learn more about our coalition at the State Patients Equal Access Coalition webpage.
Insured cancer patients are fighting for their lives, but being hit every single month with skyhigh out of pocket costs to get their life-saving cancer treatments, just because it comes in pill form. Move H206 for a vote this special session
Help SB 1034 pass the Idaho State Senate by contacting your senator today!
Please urge Senator Berger to move the Cancer Treatment Fairness Act (HB206) forward in January so that the out-of-pocket costs for oral and infusion chemotherapy are treated the same.